Profusa, Inc. Common Stock (PFSA)
NASDAQ
Healthcare
Medical - Devices
$1.06
▲ +0.00%
Market Cap
$23,608
Sector
Healthcare
Industry
Medical - Devices
Beta
0.44
52-Wk Range
0.861-1297.5
CEO
Ben Chung-Bin Hwang
Country
US
Currency
USD
Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.
Open full interactive analysis & DCF →